{"id":164673,"date":"2025-09-08T15:48:00","date_gmt":"2025-09-08T15:48:00","guid":{"rendered":"https:\/\/v2.optiknow.ca\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/"},"modified":"2025-09-08T15:48:00","modified_gmt":"2025-09-08T15:48:00","slug":"alcon-acquisition-lumithera-valeda-pbm-dmla-seche","status":"publish","type":"post","link":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/","title":{"rendered":"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che"},"content":{"rendered":"\n

Alcon<\/a> a annonc\u00e9 avoir compl\u00e9t\u00e9 l'acquisition de LumiThera<\/a>, une entreprise reconnue pour ses innovations en luminoth\u00e9rapie dans le domaine de l'ophtalmologie. Cette transaction int\u00e8gre \u00e0 son portefeuille le dispositif de photobiomodulation (PBM) Valeda\u00ae, premi\u00e8re et seule technologie d\u00e9montr\u00e9e capable d'apporter, en moyenne, une am\u00e9lioration d'une ligne d'acuit\u00e9 visuelle apr\u00e8s deux ans de traitement chez les patients atteints de d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l'\u00e2ge (DMLA) s\u00e8che aux stades pr\u00e9coce et interm\u00e9diaire.<\/p>\n\n\n\n

Jusqu'\u00e0 pr\u00e9sent, les options th\u00e9rapeutiques pour la DMLA s\u00e8che \u00e9taient limit\u00e9es et principalement propos\u00e9es aux stades avanc\u00e9s de la maladie. Avec Valeda PBM, Alcon fait son entr\u00e9e dans le domaine clinique de la r\u00e9tine, renfor\u00e7ant ainsi son leadership \u00e9tabli depuis longtemps en chirurgie r\u00e9tinienne.<\/p>\n\n\n\n

\n

\u00ab Depuis qu'Alcon est entr\u00e9e dans le domaine de la r\u00e9tine en 1997, nous avons concentr\u00e9 nos efforts surtout en chirurgie, en offrant des produits et des solutions de premier plan pour la salle d'op\u00e9ration. Avec l'int\u00e9gration de LumiThera et de Valeda PBM, nous p\u00e9n\u00e9trons maintenant le segment clinique et celui de la DMLA s\u00e8che \u00bb, a d\u00e9clar\u00e9 Ian Bell, vice-pr\u00e9sident directeur et chef de l'exploitation d'Alcon.<\/p>\n<\/blockquote>\n\n\n\n

Le dispositif Valeda PBM utilise une luminoth\u00e9rapie non phototoxique, reposant sur trois longueurs d'onde. Les donn\u00e9es issues des essais cliniques LIGHTSITE I, II et III d\u00e9montrent de fa\u00e7on constante des gains d'acuit\u00e9 visuelle, 97 % des patients n'ayant ressenti aucun inconfort pendant les traitements.<\/p>\n\n\n\n

Pour le Dr Allen C. Ho, directeur de la recherche r\u00e9tinienne au Wills Eye Hospital et pr\u00e9sident du comit\u00e9 ex\u00e9cutif de l'Alcon Research Institute, cette innovation marque un tournant : \u00ab Traiter la DMLA s\u00e8che plus t\u00f4t \u0097 avant qu'elle n'\u00e9volue vers des stades avanc\u00e9s \u0097 a toujours \u00e9t\u00e9 logique, mais nous n'avions pas de technologie capable d'am\u00e9liorer la vision jusqu'\u00e0 l'arriv\u00e9e de Valeda PBM. \u00bb<\/p>\n\n\n\n

Le dispositif est d\u00e9j\u00e0 disponible aux \u00c9tats-Unis ainsi que dans plusieurs pays d'Europe et d'Am\u00e9rique latine. Alcon pr\u00e9voit g\u00e9n\u00e9rer des revenus dans ces march\u00e9s d\u00e8s cette ann\u00e9e et, sous r\u00e9serve des approbations r\u00e9glementaires, vise une expansion dans de nouveaux pays \u00e0 compter de 2026.<\/p>\n\n\n\n

Pour plus d'information, visitez myValeda.com<\/a>.<\/p>\n\n\n\n

Source : Alcon<\/a><\/p>\n\n\n\n

Vous voulez voir plus d'articles comme celui-ci? Cliquez ici<\/a> pour vous abonner \u00e0 notre magazine imprim\u00e9 GRATUIT et \u00e0 nos infolettres!<\/p>\n","protected":false},"excerpt":{"rendered":"

Cette transaction int\u00e8gre \u00e0 son portefeuille le dispositif de photobiomodulation (PBM) Valeda\u00ae, premi\u00e8re et seule technologie d\u00e9montr\u00e9e capable d\u0092apporter, en moyenne, une am\u00e9lioration d\u0092une ligne d\u0092acuit\u00e9 visuelle apr\u00e8s deux ans de traitement chez les patients atteints de d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l\u0092\u00e2ge (DMLA) s\u00e8che aux stades pr\u00e9coce et interm\u00e9diaire.<\/p>\n","protected":false},"author":1,"featured_media":151164,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23133],"tags":[23272,27434,24055,26358,27435,27436,27437,23421,27438,27439,27440],"class_list":["post-164673","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles","tag-alcon","tag-amelioration-vision","tag-degenerescence-maculaire-liee-a-lage","tag-dmla-seche","tag-essais-cliniques-lightsite","tag-lumithera","tag-photobiomodulation","tag-professionnels-de-la-vue","tag-therapie-oculaire","tag-traitement-retine","tag-valeda-pbm"],"acf":[],"yoast_head":"\nAlcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che - OptikNow<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che - OptikNow\" \/>\n<meta property=\"og:description\" content=\"Cette transaction int\u00e8gre \u00e0 son portefeuille le dispositif de photobiomodulation (PBM) Valeda\u00ae, premi\u00e8re et seule technologie d\u00e9montr\u00e9e capable d\u0092apporter, en moyenne, une am\u00e9lioration d\u0092une ligne d\u0092acuit\u00e9 visuelle apr\u00e8s deux ans de traitement chez les patients atteints de d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l\u0092\u00e2ge (DMLA) s\u00e8che aux stades pr\u00e9coce et interm\u00e9diaire.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/\" \/>\n<meta property=\"og:site_name\" content=\"OptikNow\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-08T15:48:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Alcon-2024-logo-810-x-338.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1620\" \/>\n\t<meta property=\"og:image:height\" content=\"676\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Optiknow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Optiknow\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/\"},\"author\":{\"name\":\"Optiknow\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/person\\\/94d0fced8e14590d08b3c02ab7a8c150\"},\"headline\":\"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che\",\"datePublished\":\"2025-09-08T15:48:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/\"},\"wordCount\":443,\"publisher\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Alcon-2024-logo-810-x-338.jpg\",\"keywords\":[\"Alcon\",\"am\u00e9lioration vision\",\"d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l\u0092\u00e2ge\",\"DMLA s\u00e8che\",\"essais cliniques LIGHTSITE\",\"LumiThera\",\"photobiomodulation\",\"professionnels de la vue\",\"th\u00e9rapie oculaire\",\"traitement r\u00e9tine\",\"Valeda PBM\"],\"articleSection\":[\"Nouvelles\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/\",\"name\":\"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che - OptikNow\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Alcon-2024-logo-810-x-338.jpg\",\"datePublished\":\"2025-09-08T15:48:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/#primaryimage\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Alcon-2024-logo-810-x-338.jpg\",\"contentUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Alcon-2024-logo-810-x-338.jpg\",\"width\":1620,\"height\":676,\"caption\":\"Alcon logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/2025\\\/09\\\/08\\\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/\",\"name\":\"OptikNow\",\"description\":\"Canadian Eye Care and Eyewear News for Eye Care Professionals\",\"publisher\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#organization\",\"name\":\"OptikNow\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cropped-Optik-NOW_RGB.png\",\"contentUrl\":\"https:\\\/\\\/v2.optiknow.ca\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/cropped-Optik-NOW_RGB.png\",\"width\":1181,\"height\":250,\"caption\":\"OptikNow\"},\"image\":{\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/#\\\/schema\\\/person\\\/94d0fced8e14590d08b3c02ab7a8c150\",\"name\":\"Optiknow\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g\",\"caption\":\"Optiknow\"},\"sameAs\":[\"https:\\\/\\\/v2.optiknow.ca\"],\"url\":\"https:\\\/\\\/v2.optiknow.ca\\\/fr\\\/author\\\/optiknow\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che - OptikNow","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che - OptikNow","og_description":"Cette transaction int\u00e8gre \u00e0 son portefeuille le dispositif de photobiomodulation (PBM) Valeda\u00ae, premi\u00e8re et seule technologie d\u00e9montr\u00e9e capable d\u0092apporter, en moyenne, une am\u00e9lioration d\u0092une ligne d\u0092acuit\u00e9 visuelle apr\u00e8s deux ans de traitement chez les patients atteints de d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l\u0092\u00e2ge (DMLA) s\u00e8che aux stades pr\u00e9coce et interm\u00e9diaire.","og_url":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/","og_site_name":"OptikNow","article_published_time":"2025-09-08T15:48:00+00:00","og_image":[{"width":1620,"height":676,"url":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Alcon-2024-logo-810-x-338.jpg","type":"image\/jpeg"}],"author":"Optiknow","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Optiknow","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/#article","isPartOf":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/"},"author":{"name":"Optiknow","@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/person\/94d0fced8e14590d08b3c02ab7a8c150"},"headline":"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che","datePublished":"2025-09-08T15:48:00+00:00","mainEntityOfPage":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/"},"wordCount":443,"publisher":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#organization"},"image":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/#primaryimage"},"thumbnailUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Alcon-2024-logo-810-x-338.jpg","keywords":["Alcon","am\u00e9lioration vision","d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l\u0092\u00e2ge","DMLA s\u00e8che","essais cliniques LIGHTSITE","LumiThera","photobiomodulation","professionnels de la vue","th\u00e9rapie oculaire","traitement r\u00e9tine","Valeda PBM"],"articleSection":["Nouvelles"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/","url":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/","name":"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che - OptikNow","isPartOf":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/#primaryimage"},"image":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/#primaryimage"},"thumbnailUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Alcon-2024-logo-810-x-338.jpg","datePublished":"2025-09-08T15:48:00+00:00","breadcrumb":{"@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/#primaryimage","url":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Alcon-2024-logo-810-x-338.jpg","contentUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/Alcon-2024-logo-810-x-338.jpg","width":1620,"height":676,"caption":"Alcon logo"},{"@type":"BreadcrumbList","@id":"https:\/\/v2.optiknow.ca\/fr\/2025\/09\/08\/alcon-acquisition-lumithera-valeda-pbm-dmla-seche\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/v2.optiknow.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Alcon finalise l\u0092acquisition de LumiThera et \u00e9largit son offre pour la DMLA s\u00e8che"}]},{"@type":"WebSite","@id":"https:\/\/v2.optiknow.ca\/fr\/#website","url":"https:\/\/v2.optiknow.ca\/fr\/","name":"OptikNow","description":"Canadian Eye Care and Eyewear News for Eye Care Professionals","publisher":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/v2.optiknow.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/v2.optiknow.ca\/fr\/#organization","name":"OptikNow","url":"https:\/\/v2.optiknow.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/cropped-Optik-NOW_RGB.png","contentUrl":"https:\/\/v2.optiknow.ca\/wp-content\/uploads\/2025\/10\/cropped-Optik-NOW_RGB.png","width":1181,"height":250,"caption":"OptikNow"},"image":{"@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/v2.optiknow.ca\/fr\/#\/schema\/person\/94d0fced8e14590d08b3c02ab7a8c150","name":"Optiknow","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c3d9d9d3666433885d21222832323ad61203639f9ec9a592770d278c8df76db1?s=96&d=mm&r=g","caption":"Optiknow"},"sameAs":["https:\/\/v2.optiknow.ca"],"url":"https:\/\/v2.optiknow.ca\/fr\/author\/optiknow\/"}]}},"_links":{"self":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/posts\/164673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/comments?post=164673"}],"version-history":[{"count":0,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/posts\/164673\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/media\/151164"}],"wp:attachment":[{"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/media?parent=164673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/categories?post=164673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/v2.optiknow.ca\/fr\/wp-json\/wp\/v2\/tags?post=164673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}